Pricing Log in Create free account

Lipella Pharmaceuticals Inc. (LIPO) vs Traws Pharma, Inc. (TRAW)

Lipella Pharmaceuticals Inc. and Traws Pharma, Inc. are both Biotechnology companies. Lipella Pharmaceuticals Inc. and Traws Pharma, Inc. are of similar size ($3.4M and $3.4M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −7.29%. Across the 11 metrics below, Traws Pharma, Inc. leads on 7 and Lipella Pharmaceuticals Inc. on 4.

Valuation

Metric LIPO TRAW Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.28 9.40
P/B n/m 2.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.29 0.06 0.66
EV/Sales (3.31) (0.48) 9.02
Earnings yield 0.00% (656.52%) (32.88%)
Free cash flow yield 0.00% (462.16%) (23.13%)

Profitability

Metric LIPO TRAW Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (361.77%) (336.30%) (51.96%)
Return on assets (236.36%) (123.55%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LIPO TRAW Biotechnology median
Revenue growth (TTM) (7.29%) 1,159.29% 6.76%
EPS growth (last fiscal year) 22.24% 102.33% 29.88%
Revenue growth, 5-year CAGR (5.04%) 64.59% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIPO TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 0.93 4.97
Net debt to EBITDA 0.43 0.21 1.01

Dividend

Metric LIPO TRAW Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LIPO TRAW Biotechnology median
Market cap 3.39m 3.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack